- $2.25bn
- $14.02bn
- $2.26bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 859 | 922 | 1,610 | 2,321 | 2,260 |
Cost of Revenue | |||||
Gross Profit | 213 | 179 | 244 | 299 | 163 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,074 | 1,387 | 2,276 | 2,984 | 4,238 |
Operating Profit | -216 | -465 | -666 | -662 | -1,979 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -399 | -688 | -971 | -847 | -2,696 |
Provision for Income Taxes | |||||
Net Income After Taxes | -391 | -627 | -981 | -850 | -2,683 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 26.3 | -173 | -79.4 | 173 | -1,604 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 26.3 | -173 | -79.4 | 173 | -1,604 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.213 | -1.24 | -0.387 | 0.791 | -3.93 |